1-17 of 17
Keywords: Vascular smooth muscle cell
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles
Clin Sci (Lond) (2021) 135 (13): 1557–1561.
Published: 30 June 2021
...Cali B. Corbett; Amanda K. St. Paul; Michael V. Autieri As many as 70% of cells in atherosclerotic plaque are vascular smooth muscle cell (VSMC) in origin, and pathways and proteins which regulate VSMC migration, proliferation, and phenotype modulation represent novel targets for rational drug...
Articles
Clin Sci (Lond) (2019) 133 (16): 1779–1796.
Published: 20 August 2019
... above) corresponding to various in vitro experiments. Atherosclerosis is narrowing of the arteries caused by a buildup of intimal plaques containing lipid-laden macrophage foam cells, vascular smooth muscle cells (VSMCs), and extracellular matrix (ECM) [ 1 ]. Atherosclerosis is triggered...
Includes: Supplementary data
Articles
Clin Sci (Lond) (2018) 132 (23): 2493–2507.
Published: 05 December 2018
...@toyaku.ac.jp ) 29 05 2018 11 10 2018 05 11 2018 06 11 2018 © 2018 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society 2018 atherosclerosis endothelial cell macrophage vasostatin-1 vascular smooth muscle cell Atherosclerosis...
Includes: Supplementary data
Articles
Articles
Clin Sci (Lond) (2011) 120 (4): 131–141.
Published: 02 November 2010
... in vascular biology. Correspondence: Dr Augusto C. Montezano (email amonteza@uottawa.ca ). 20 7 2010 1 9 2010 14 9 2010 In heterologously expressing cells [ 23 ], endothelial cells [ 18 ] and vascular smooth muscle cells [ 33 ], Nox4 has a strong immunofluorescence...
Articles
Clin Sci (Lond) (2010) 118 (3): 159–172.
Published: 26 October 2009
... in thrombosis, TF has pro-atherogenic properties, as it is involved in neointima formation by inducing vascular smooth muscle cell migration. As inhibition of TF action appears to be an attractive target for the treatment of cardiovascular disease, therapeutic strategies are under investigation to specifically...
Articles
Clin Sci (Lond) (2009) 116 (5): 391–399.
Published: 02 February 2009
... © The Authors Journal compilation © 2009 Biochemical Society 2009 blood pressure cardiac myocyte G-protein-coupled receptor heterotrimeric GTP-binding protein regulator of G-protein signalling (RGS) vascular smooth muscle cell Hypertension is a prevalent condition within...
Articles
Clin Sci (Lond) (2008) 114 (4): 257–264.
Published: 15 January 2008
... migration neointima remodelling restenosis vascular smooth muscle cell Atherosclerotic stenosis and its ischaemic complications necessitate arterial reconstruction. Current therapeutic strategies to restore blood flow in stenotic coronary arteries include percutaneous transluminal angioplasty...
Articles
Clin Sci (Lond) (2008) 114 (1): 37–47.
Published: 30 November 2007
.... aldosterone collagen deposition epidermal growth factor receptor (EGFR) ischaemia mineralocorticoid receptor (MR) stroke vascular smooth muscle cell Correspondence: Dr Anne M. Dorrance, at the present address: Department of Pharmacology/Toxicology, Michigan State University, East Lansing, MI...
Articles
Clin Sci (Lond) (2007) 112 (8): 417–428.
Published: 13 March 2007
... type-1 receptor), a G-protein-coupled receptor, mediates most of the physiological and pathophysiological actions of AngII, and this receptor is predominantly expressed in cardiovascular cells, such as VSMCs (vascular smooth muscle cells). AngII activates various signalling molecules, including G...
Articles
Clin Sci (Lond) (2006) 111 (2): 107–118.
Published: 13 July 2006
... have been shown to influence activation of the nuclear transcription factor NF-κB (nuclear factor κB), which is involved in the regulation of adhesion molecule expression in ECs [ 45 ]. cardiovascular disease endothelial cell gender-associated protection oestrogen vascular smooth muscle cell...
Articles
Articles
Articles
Articles
Articles
Clin Sci (Lond) (1999) 96 (6): 605–612.
Published: 07 May 1999
.... In this lesion we identified apoptosis of vascular smooth muscle cells (VSMCs) by in situ DNA labelling and electron microscopy in the neointima on the 14th day after injury. mRNA expression levels of bcl-2 , bax , bcl-x , p53 and caspase-1 were determined by the reverse transcriptase–polymerase chain reaction...
Articles